BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 22264443)

  • 1. β-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner.
    Nguyen PT; Schmid CL; Raehal KM; Selley DE; Bohn LM; Sim-Selley LJ
    Biol Psychiatry; 2012 Apr; 71(8):714-24. PubMed ID: 22264443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
    Falenski KW; Thorpe AJ; Schlosburg JE; Cravatt BF; Abdullah RA; Smith TH; Selley DE; Lichtman AH; Sim-Selley LJ
    Neuropsychopharmacology; 2010 Jul; 35(8):1775-87. PubMed ID: 20357755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
    Smith PA; Selley DE; Sim-Selley LJ; Welch SP
    Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice.
    Sim-Selley LJ; Martin BR
    J Pharmacol Exp Ther; 2002 Oct; 303(1):36-44. PubMed ID: 12235230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance: a role for RAS-ERK cascade.
    Rubino T; Viganò D; Premoli F; Castiglioni C; Bianchessi S; Zippel R; Parolaro D
    Mol Neurobiol; 2006 Jun; 33(3):199-213. PubMed ID: 16954596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol.
    McKinney DL; Cassidy MP; Collier LM; Martin BR; Wiley JL; Selley DE; Sim-Selley LJ
    J Pharmacol Exp Ther; 2008 Feb; 324(2):664-73. PubMed ID: 17967938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol.
    Romero J; Berrendero F; García-Gil L; Ramos JA; Fernández-Ruiz JJ
    J Mol Neurosci; 1998 Oct; 11(2):109-19. PubMed ID: 10096037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain.
    Sim LJ; Hampson RE; Deadwyler SA; Childers SR
    J Neurosci; 1996 Dec; 16(24):8057-66. PubMed ID: 8987831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of beta-arrestin1 deletion on acute cannabinoid activity, brain cannabinoid receptors and tolerance to cannabinoids in mice.
    Breivogel CS; Vaghela MS
    J Recept Signal Transduct Res; 2015 Feb; 35(1):98-106. PubMed ID: 25779032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid Tolerance in S426A/S430A x
    Piscura MK; Sepulveda DE; Maulik M; Guindon J; Henderson-Redmond AN; Morgan DJ
    J Pharmacol Exp Ther; 2023 Apr; 385(1):17-34. PubMed ID: 36669876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids.
    Sim-Selley LJ
    Crit Rev Neurobiol; 2003; 15(2):91-119. PubMed ID: 14977366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ΔFosB induction correlates inversely with CB₁ receptor desensitization in a brain region-dependent manner following repeated Δ⁹-THC administration.
    Lazenka MF; Selley DE; Sim-Selley LJ
    Neuropharmacology; 2014 Feb; 77():224-33. PubMed ID: 24090766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of beta-arrestin2 on cannabinoid CB1 receptor coupling to G-proteins and subcellular localization and relative levels of beta-arrestin1 and 2 in mouse brain.
    Breivogel CS; Puri V; Lambert JM; Hill DK; Huffman JW; Razdan RK
    J Recept Signal Transduct Res; 2013 Dec; 33(6):367-79. PubMed ID: 24094141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects.
    Rubino T; Forlani G; Viganò D; Zippel R; Parolaro D
    J Neurochem; 2005 May; 93(4):984-91. PubMed ID: 15857401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex, THC, and hormones: Effects on density and sensitivity of CB
    Farquhar CE; Breivogel CS; Gamage TF; Gay EA; Thomas BF; Craft RM; Wiley JL
    Drug Alcohol Depend; 2019 Jan; 194():20-27. PubMed ID: 30391834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta FosB and AP-1-mediated transcription modulate cannabinoid CB₁ receptor signaling and desensitization in striatal and limbic brain regions.
    Lazenka MF; David BG; Lichtman AH; Nestler EJ; Selley DE; Sim-Selley LJ
    Biochem Pharmacol; 2014 Oct; 91(3):380-9. PubMed ID: 25093286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in mice.
    Morgan DJ; Davis BJ; Kearn CS; Marcus D; Cook AJ; Wager-Miller J; Straiker A; Myoga MH; Karduck J; Leishman E; Sim-Selley LJ; Czyzyk TA; Bradshaw HB; Selley DE; Mackie K
    J Neurosci; 2014 Apr; 34(15):5152-63. PubMed ID: 24719095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184.
    Feliszek M; Bindila L; Lutz B; Zimmer A; Bilkei-Gorzo A; Schlicker E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):603-12. PubMed ID: 26984820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.
    Deng L; Guindon J; Cornett BL; Makriyannis A; Mackie K; Hohmann AG
    Biol Psychiatry; 2015 Mar; 77(5):475-87. PubMed ID: 24853387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity to delta9-tetrahydrocannabinol is selectively enhanced in beta-arrestin2 -/- mice.
    Breivogel CS; Lambert JM; Gerfin S; Huffman JW; Razdan RK
    Behav Pharmacol; 2008 Jul; 19(4):298-307. PubMed ID: 18622177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.